Myasthenia gravis and the Miller-Fisher variant of Guillain-Barre syndrome

Current Opinion in Neurology

Volumn 10, Issue 1, 1997, Pages 18-21

  Newsom Davis, John ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; GANGLIOSIDE ANTIBODY;

EXTRAOCULAR MUSCLE; GRAVES DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; MUSCLE FUNCTION; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; OPHTHALMOPLEGIA; SHORT SURVEY; SUBCLAVIAN STEAL SYNDROME;

EID: 0030967475     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199702000-00005     Document Type: Short Survey

References (23)

1. Kaminski HJ, Maas E, Spiegel P, Ruff RL: Why are eye muscles frequently involved in myasthenia gravis? Neurology 1990, 40:1663-1669.
2. Oda K, Shibasaki H: Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle. Brain Res 1988, 449:337-340.
3. Norton RM, Manfredi AA, Conti-Tronconi BM: The 'embryonic' gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle. Neurology 1993, 43:983-986.
4. Kaminski HJ, Kusner LL, Block CH: Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest Ophthalmol Vis Sci 1996, 37:345-351. The authors used polyclonal antibodies to fetal and adult AChRs to investigate the pattern of expression of AChR isoforms in rat extraocular and limb muscles.
5. Newsom-Davis J, Vincent A, Willcox N: Autoimmune disorders of the neuromuscular junction. In Clinical aspects of immunology. Edited by Lachmann PJ, Peters DK, Rosen FS, Walport MJ. Oxford: Blackwell Scientific Publications; 1993:2091-2111.
6. Vincent A, Newland C, Brueton L, Beeson D, Riemersma S, Huson SM, Newsom-Davis J: Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 1995, 346:24-25. A maternal antibody specific for fetal (rather than adult) AChR associated with recurrent arthrogryposis multiplex congenita but caused no symptoms in the mother, arguing against a major role for antifetal AChR antibodies in causing EOM weakness.
7. MacLennan C, Beeson D, Vincent A, Newsom-Davis J: Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neuron 1997 (In press). The authors used the semi quantitative RNase protection assay to show the level of γ-subunit mRNA relative to α-, β- and δ-subunits in human extraocular muscle was similar to that in innervated limb muscle while, in contrast, the ε-subunit was expressed at much higher levels.
8. Kaminski HJ, Kusner LL, Nash KV, Ruff RL: The γ-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris. Neurology 1995, 45:516-518.
9. Jacobson DM: Acetylcholine receptor antibodies in patients with Graves' ophthalmopathy. J Neuro-Ophthalmology 1995, 15:166-170.
10. Barton JJS, Jama A, Sharpe JA: Saccadic duration and intrasaccadic fatigue in myasthenic and nonmyasthenic ocular palsies. Neurology 1995, 45:2065-2072.
11. Sommer N, Melms A, Weller M, Dichgans J: Ocular myasthenia gravis: a critical review of clinical and pathophysiological aspects. Documenta Ophthalmologica 1993, 84:309-333.
12. Kupersmith MJ, Moster M, Bhuiyan S, Warren F, Weinberg H: Beneficial effects of corticosteroids on ocular myasthenia gravis. Arch Neurol 1996, 53:802-804.
13. Fisher M: An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Eng J Med 1956, 255:57-65.
14. Chiba A, Kusonoki S, Obata H, Machinami R, Kanazawa I: Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993, 43:1911-1917.
15. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T: An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci 1993, 118:83-87.
16. Yuki N: Successful plasmapheresis in Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody. J Neurol Sci 1995, 131:108-110.
17. Yuki N, Wakabayashi K, Yamada M, Seki K: Overlap of Guillain-Barré syndrome and Bickerstaff's brainstem encephalitis. J Neurol Sci 1996 (In press).
18. Kohler A, De Torrentè A, Inderwildi B: Fisher's syndrome associated with Campylobacter jejuni infection. Eur Neurol 1988, 28:150-151
19. Jacobs BC, Endtz HPh, van der Meché FGA, Hazenberg MP, Achtereekte AM, van Doom PA: Serum anti-GQ1b IgG antibodies recognize surface editopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 1995, 37:260-264. Recognition of surface determinants on C. jejuni from MFS patients by their serum anti-GQ1b antibodies further implicates C. jejuni in provoking a potentially crossreactive antibody response.
20. Yuki N, Taki T, Takahashi M, Saito K, Yoshino H, Tai T, Handa S, Miyatake T: Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994, 36:791-793.
21. Roberts M, Willison H, Vincent A, Newsom-Davis J: Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 1994, 343:454-455.
22. Buchwald B, Weishaupt A, Toyka KV, Dudel J: Immunoglobulin G from a patient with Miller Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Letts 1995, 201:163-166. This study provided further evidence that anti-GQ1b serum in MFS can interfere with neurotransmitter release.
23. Yuki N: Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol 1996, 39:668-672. Detection of serum anti-GQ1b antibody in patients with acute ocular motor palsies who lack other features of MFS suggested that immune mechanisms may be involved, and should prompt a search for these antibodies in other similar cases.